Precigen, Inc. short interest in 2025
In 2025, Precigen, Inc.'s disclosed short interest ran from 6.44% of shares outstanding on 15 Jan 2025 to 10.06% on 31 Dec 2025, a change of +3.62 percentage points. The year's high was 12.67% on 30 Sep 2025 and its low 6.44% on 15 Jan 2025, averaging 9.17% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.55 days on 30 Apr 2025. Full history: Precigen, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 6.44% (15 Jan 2025)
- End of year
- 10.06% (31 Dec 2025)
- Change
- +3.62 pp
- High
- 12.67% (30 Sep 2025)
- Low
- 6.44% (15 Jan 2025)
- Average
- 9.17%
- Highest days to cover
- 23.55 (30 Apr 2025)
- SEC filings marked
- 7
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 6.44% | 7.72 | |
| 31 Jan 2025 | 6.50% | 11.29 | |
| 14 Feb 2025 | 6.50% | 7.54 | |
| 28 Feb 2025 | 7.37% | 9.42 | |
| 14 Mar 2025 | 7.74% | 18.16 | |
| 31 Mar 2025 | 8.16% | 16.88 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 8.66% | 16.37 | |
| 30 Apr 2025 | 9.39% | 23.55 | |
| 15 May 2025 | 9.74% | 16.60 | 10-Q filed, results (8-K) |
| 30 May 2025 | 9.36% | 16.13 | |
| 13 Jun 2025 | 9.24% | 17.45 | |
| 30 Jun 2025 | 9.84% | 14.21 | |
| 15 Jul 2025 | 9.63% | 10.93 | |
| 31 Jul 2025 | 9.68% | 8.59 | |
| 15 Aug 2025 | 10.37% | 1.68 | 10-Q filed |
| 29 Aug 2025 | 12.13% | 2.52 | |
| 15 Sep 2025 | 11.86% | 5.43 | |
| 30 Sep 2025 | 12.67% | 5.63 | |
| 15 Oct 2025 | 10.75% | 6.58 | |
| 31 Oct 2025 | 9.70% | 7.46 | |
| 14 Nov 2025 | 8.16% | 5.78 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 8.32% | 6.77 | |
| 15 Dec 2025 | 7.85% | 9.81 | |
| 31 Dec 2025 | 10.06% | 5.15 |
See also: Precigen, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.